Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation: a surgical perspective.

M O Perry1

  • 1Department of Surgery, New York Hospital-Cornell Medical Center, New York 10021.

American Journal of Surgery
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the shoulders of giants.

Cardiovascular surgery (London, England)·2002
Same author

Surgical reminiscences: thinking on your feet.

Archives of surgery (Chicago, Ill. : 1960)·2000
Same author

Blunt disruption of the abdominal aorta: report of a case and review of the literature.

Journal of vascular surgery·1997
Same author

What's new in vascular surgery.

Journal of the American College of Surgeons·1997
Same author

Role of the national and regional vascular societies in shaping the future of vascular surgery.

Journal of vascular surgery·1996
Same author

Vascular trauma.

Advances in surgery·1995
Same journal

Innovative management of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): A meta-analysis and introduction of a new robotic approach with patient-based algorithm.

American journal of surgery·2026
Same journal

Does the risk outweigh the benefit? Clot progression, recanalization & complications of anticoagulation therapy in acute pancreatitis with concomitant splanchnic vein thrombosis.

American journal of surgery·2026
Same journal

High and low body mass index and 90-day postoperative outcomes in patients with Crohn's disease undergoing abdominal surgery.

American journal of surgery·2026
Same journal

Women with firearm injuries: A multicenter mixed-methods study.

American journal of surgery·2026
Same journal

SBAS presidential address: A surgeon-scientist's journey from haptic science to digital performance metrics.

American journal of surgery·2026
Same journal

Using Dr. Google and AI to stay informed.

American journal of surgery·2026
See all related articles

Heparin and warfarin are anticoagulants used to treat thromboembolism. Understanding their pharmacologic actions and interactions is crucial for effective treatment.

Area of Science:

  • Pharmacology
  • Hematology

Background:

  • Heparin and warfarin are critical anticoagulants for managing thromboembolism.
  • Their distinct mechanisms of action and pharmacokinetic profiles necessitate careful clinical consideration.

Purpose of the Study:

  • To elucidate the pharmacologic mechanisms of heparin and warfarin.
  • To highlight the importance of understanding drug interactions in anticoagulant therapy.

Main Methods:

  • Review of the biochemical pathways affected by heparin and warfarin.
  • Analysis of pharmacokinetic data for both drugs.

Main Results:

  • Heparin, combined with antithrombin III, inactivates clotting factors, primarily by inhibiting factor X to Xa conversion.
  • Warfarin interferes with vitamin K-dependent synthesis of prothrombin and factors VII, IX, and X.

Related Experiment Videos

  • Heparin has a short half-life (~90 minutes) with rapid clearance, while warfarin has a long half-life and delayed onset of action (4-5 days).
  • Conclusions:

    • Effective thromboembolism treatment with sequential heparin and warfarin therapy depends on a thorough grasp of their pharmacology.
    • Awareness of potential drug interactions is essential for optimizing patient outcomes.